Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: Results of a collaborative study

A. Cassio, A. Corrias, S. Gualandi, L. Tato', G. Cesaretti, C. Volta, G. Weber, G. Bona, M. Cappa, M. Bal, J. Bellone, A. Cicognani

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate the influence of sex as well as pubertal stage at diagnosis on the growth outcome of childhood thyrotoxicosis. Design: Retrospective, collaborative study. Patients and methods: Longitudinal auxological evaluation in 101 patients (M/F 23/78) for 4.7 ± 3.1 years subdivided according to pubertal stage at diagnosis into prepubertal (group I) and pubertal (group II). Results: At diagnosis height and bone age (BA) standard deviation score (SDS) were positive both in girls and boys of groups I and II. In boys of group II, height SDS was significantly higher than in girls of the same group (P = 0.007) and in boys of group I (P = 0.026). During the follow-up, in group I, height SDS remained positive without significant differences between boys and girls, and in group II, height SDS remained significantly lower in girls than in boys. The age at onset of puberty and the age at menarche were within the normal range. Final height (FH) was within target height (TH) range in all groups The FH SDS and the height gain (FH-TH) were similar in girls and in boys in group I and significantly higher in boys than in girls (P <0.05) in group II. The boys of group II showed a mean height gain significantly greater than that found in all the other groups. Conclusions: Despite the advancement of BA at presentation, there were no adverse effects on subsequent growth and FH; the growth outcome seems to be better in boys than in girls in group II.

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalClinical Endocrinology
Volume64
Issue number1
DOIs
Publication statusPublished - Jan 2006

Fingerprint

Thyrotoxicosis
Growth
Bone and Bones
Menarche
Puberty
Age of Onset
Reference Values
Retrospective Studies

ASJC Scopus subject areas

  • Endocrinology

Cite this

Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis : Results of a collaborative study. / Cassio, A.; Corrias, A.; Gualandi, S.; Tato&apos;, L.; Cesaretti, G.; Volta, C.; Weber, G.; Bona, G.; Cappa, M.; Bal, M.; Bellone, J.; Cicognani, A.

In: Clinical Endocrinology, Vol. 64, No. 1, 01.2006, p. 53-57.

Research output: Contribution to journalArticle

Cassio, A, Corrias, A, Gualandi, S, Tato&apos;, L, Cesaretti, G, Volta, C, Weber, G, Bona, G, Cappa, M, Bal, M, Bellone, J & Cicognani, A 2006, 'Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: Results of a collaborative study', Clinical Endocrinology, vol. 64, no. 1, pp. 53-57. https://doi.org/10.1111/j.1365-2265.2005.02415.x
Cassio, A. ; Corrias, A. ; Gualandi, S. ; Tato&apos;, L. ; Cesaretti, G. ; Volta, C. ; Weber, G. ; Bona, G. ; Cappa, M. ; Bal, M. ; Bellone, J. ; Cicognani, A. / Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis : Results of a collaborative study. In: Clinical Endocrinology. 2006 ; Vol. 64, No. 1. pp. 53-57.
@article{109330d1d4154f6cb8af846e9689f235,
title = "Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: Results of a collaborative study",
abstract = "Objective: To evaluate the influence of sex as well as pubertal stage at diagnosis on the growth outcome of childhood thyrotoxicosis. Design: Retrospective, collaborative study. Patients and methods: Longitudinal auxological evaluation in 101 patients (M/F 23/78) for 4.7 ± 3.1 years subdivided according to pubertal stage at diagnosis into prepubertal (group I) and pubertal (group II). Results: At diagnosis height and bone age (BA) standard deviation score (SDS) were positive both in girls and boys of groups I and II. In boys of group II, height SDS was significantly higher than in girls of the same group (P = 0.007) and in boys of group I (P = 0.026). During the follow-up, in group I, height SDS remained positive without significant differences between boys and girls, and in group II, height SDS remained significantly lower in girls than in boys. The age at onset of puberty and the age at menarche were within the normal range. Final height (FH) was within target height (TH) range in all groups The FH SDS and the height gain (FH-TH) were similar in girls and in boys in group I and significantly higher in boys than in girls (P <0.05) in group II. The boys of group II showed a mean height gain significantly greater than that found in all the other groups. Conclusions: Despite the advancement of BA at presentation, there were no adverse effects on subsequent growth and FH; the growth outcome seems to be better in boys than in girls in group II.",
author = "A. Cassio and A. Corrias and S. Gualandi and L. Tato&apos; and G. Cesaretti and C. Volta and G. Weber and G. Bona and M. Cappa and M. Bal and J. Bellone and A. Cicognani",
year = "2006",
month = "1",
doi = "10.1111/j.1365-2265.2005.02415.x",
language = "English",
volume = "64",
pages = "53--57",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis

T2 - Results of a collaborative study

AU - Cassio, A.

AU - Corrias, A.

AU - Gualandi, S.

AU - Tato&apos;, L.

AU - Cesaretti, G.

AU - Volta, C.

AU - Weber, G.

AU - Bona, G.

AU - Cappa, M.

AU - Bal, M.

AU - Bellone, J.

AU - Cicognani, A.

PY - 2006/1

Y1 - 2006/1

N2 - Objective: To evaluate the influence of sex as well as pubertal stage at diagnosis on the growth outcome of childhood thyrotoxicosis. Design: Retrospective, collaborative study. Patients and methods: Longitudinal auxological evaluation in 101 patients (M/F 23/78) for 4.7 ± 3.1 years subdivided according to pubertal stage at diagnosis into prepubertal (group I) and pubertal (group II). Results: At diagnosis height and bone age (BA) standard deviation score (SDS) were positive both in girls and boys of groups I and II. In boys of group II, height SDS was significantly higher than in girls of the same group (P = 0.007) and in boys of group I (P = 0.026). During the follow-up, in group I, height SDS remained positive without significant differences between boys and girls, and in group II, height SDS remained significantly lower in girls than in boys. The age at onset of puberty and the age at menarche were within the normal range. Final height (FH) was within target height (TH) range in all groups The FH SDS and the height gain (FH-TH) were similar in girls and in boys in group I and significantly higher in boys than in girls (P <0.05) in group II. The boys of group II showed a mean height gain significantly greater than that found in all the other groups. Conclusions: Despite the advancement of BA at presentation, there were no adverse effects on subsequent growth and FH; the growth outcome seems to be better in boys than in girls in group II.

AB - Objective: To evaluate the influence of sex as well as pubertal stage at diagnosis on the growth outcome of childhood thyrotoxicosis. Design: Retrospective, collaborative study. Patients and methods: Longitudinal auxological evaluation in 101 patients (M/F 23/78) for 4.7 ± 3.1 years subdivided according to pubertal stage at diagnosis into prepubertal (group I) and pubertal (group II). Results: At diagnosis height and bone age (BA) standard deviation score (SDS) were positive both in girls and boys of groups I and II. In boys of group II, height SDS was significantly higher than in girls of the same group (P = 0.007) and in boys of group I (P = 0.026). During the follow-up, in group I, height SDS remained positive without significant differences between boys and girls, and in group II, height SDS remained significantly lower in girls than in boys. The age at onset of puberty and the age at menarche were within the normal range. Final height (FH) was within target height (TH) range in all groups The FH SDS and the height gain (FH-TH) were similar in girls and in boys in group I and significantly higher in boys than in girls (P <0.05) in group II. The boys of group II showed a mean height gain significantly greater than that found in all the other groups. Conclusions: Despite the advancement of BA at presentation, there were no adverse effects on subsequent growth and FH; the growth outcome seems to be better in boys than in girls in group II.

UR - http://www.scopus.com/inward/record.url?scp=33644957821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644957821&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2265.2005.02415.x

DO - 10.1111/j.1365-2265.2005.02415.x

M3 - Article

C2 - 16402928

AN - SCOPUS:33644957821

VL - 64

SP - 53

EP - 57

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 1

ER -